Amarin Corp Plc (AMRN)

[hamkypamky]

Ham, I didn’t think GL would be pushed by doctors and covered by insurance companies for the ReduceIT indication either. Different medication, much less EPA and has DHA, failed trials, and doesn’t have a CVD indication but it’s still prescribed by doctors and covered and covered by payers.

1. Lovaza is owned by a mega-pharma (bigger than your run-of-the-mill BP), GSK
2. Lovaza is the incumbent (ie the original O3 drug) and has been approved for more than 15 years, way before AMRN, meaning there is still inertia from "the old way of doing things"
3. GenL is significantly cheaper than Vascepa (which whatever snake oil KD is pushing most likely won't be).
4. AMRN hasn't managed to get good coverage everywhere yet due to Adcomm, etc which means some patients have no option except GenL
5. In spite of 1-4, GenL scripts have been steadily declining for months.

This tells me you need to relax a little man. Evne if by some miracle KD succeeds in its CoVid approval, it will flop.